This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Harvest Technologies Corporation Files Amended Patent Infringement Complaint Against ThermoGenesis Corporation And Celling Technologies LLC

PLYMOUTH, Mass., Feb. 20, 2013 /PRNewswire/ --  Harvest Technologies Corporation (Harvest) announced that it filed an amended patent infringement complaint on February 15, 2013 in the US District Court of Delaware against ThermoGenesis Corporation (ThermoGenesis) and Celling Technologies LLC.  The complaint was amended to include Celling Technologies and alleges that the ThermoGenesis' Res-Q™ 60 BMC system, also sold by Celling Technologies as the ART 21 ® BMC System, infringes two patents for which Harvest Technology owns the rights.  These patents relate to Harvest's proprietary floating shelf technology that has been shown in studies to provide superior cellular concentration.  The complaint also requests an injunction against further sales of the product in the U.S.

"Harvest Technologies has invested many years and millions of dollars in development of its cellular therapy products," said Gael Tisack, Vice President of Intellectual Property for Terumo Americas Holding.  "We will continue to take all steps necessary to ensure that we protect our intellectual property and enforce our patent rights."

Harvest Technologies is the leading cellular therapy global manufacturer that has developed       point-of-care products to process and concentrate multiple biologics.  These include high-density platelet rich plasma (APC + ®), bone marrow aspirate concentrate (BMAC ®) and adipose tissue.  The company is headquartered in Plymouth, Massachusetts.  It is one of several subsidiaries of Terumo Corporation of Japan that is focused in cellular therapies and biologics.  For more information, visit www.harvesttech.com or call 508-732-7500.

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with    $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.

Harvest is a registered trademark of Harvest Technologies Corporation.  Terumo ® is a registered trademark of Terumo Corporation. Res-Q is a trademark of ThermoGenesis Corporation.  Celling Technologies ® is a registered trademark of Celling Technologies LLC.  ART 21 is a trademark of Celling Technologies ®

SOURCE Harvest Technologies Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,979.13 +59.54 0.35%
S&P 500 1,986.51 +4.91 0.25%
NASDAQ 4,526.4820 -1.0320 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs